TELA Bio (TELA) Share-based Compensation (QoQ) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | TELA Bio | 13.26 Mn | -26.28 Mn | 12.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.49% |
| Dec 31, 2025 | -14.97% |
| Sep 30, 2025 | -3.05% |
| Jun 30, 2025 | -5.65% |
| Mar 31, 2025 | -4.13% |
| Dec 31, 2024 | 0.74% |
| Sep 30, 2024 | -0.83% |
| Jun 30, 2024 | -1.09% |
| Mar 31, 2024 | -11.20% |
| Dec 31, 2023 | -9.35% |
| Sep 30, 2023 | 5.80% |
| Jun 30, 2023 | 14.72% |
| Mar 31, 2023 | 8.57% |
| Dec 31, 2022 | 1.17% |
| Sep 30, 2022 | 0.49% |
| Jun 30, 2022 | 13.43% |
| Mar 31, 2022 | 9.61% |
| Dec 31, 2021 | 12.14% |
| Sep 30, 2021 | -48.09% |
| Jun 30, 2021 | 103.46% |
| Mar 31, 2021 | 21.33% |
| Dec 31, 2020 | 5.34% |
| Sep 30, 2020 | 9.92% |
| Jun 30, 2020 | 10.02% |
| Mar 31, 2020 | 63.87% |
| Dec 31, 2019 | 328.13% |
| Sep 30, 2019 | 8.47% |
| Jun 30, 2019 | -1.67% |
| Mar 31, 2019 | 27.66% |
| Dec 31, 2018 | -22.95% |